ELECTROMEDICAL TECHNOLOGIES, INC.
Cash Flow Statement
| Line Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-2.6M | $-3.5M | $-8.5M | $-3.9M | $-1.7M |
| Depreciation & Amortization | $4.6K | $21.9K | $21.9K | $21.9K | $24.5K |
| Depreciation | — | — | — | — | — |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $715.0K | $509.6K | $2.6M | $2.2M | $801.3K |
| Net Cash from Operating Activities | $-1.4M | $-773.3K | $-1.2M | $-1.3M | $-280.8K |
| Investing Activities | |||||
| Capital Expenditures | $149.7K | — | — | — | — |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $1.7M | — | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $-608.2K | $758.6K | $1.3M | $1.6M | $280.8K |
| Net Change in Cash | $-280.7K | $-14.7K | $118.3K | $264.9K | — |
| Free Cash Flow | $-1.6M | — | — | — | — |